Companies allegedly making deceptive claims
Silver Spring, Maryland—(ENEWSPF)—January 25, 2018
By: Lyndsay Meyer
The U.S. Food and Drug Administration and the Federal Trade Commission today posted joint warning letters to the marketers and distributors of 12 opioid cessation products, for illegally marketing unapproved products with claims about their ability to help in the treatment of opioid addiction and withdrawal.
“The FDA is increasingly concerned with the proliferation of products claiming to treat or…
